Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio?

Tianjin Pharmaceutical Da Ren Tang Group's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 0.80, which seems too high.

The historical rank and industry rank for Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio or its related term are showing as below:

SHSE:600329' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.32 Max: 0.91
Current: 0.8

During the past 13 years, the highest Dividend Payout Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 0.91. The lowest was 0.11. And the median was 0.32.

SHSE:600329's Dividend Payout Ratio is ranked worse than
86.92% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs SHSE:600329: 0.80

As of today (2024-04-29), the Dividend Yield % of Tianjin Pharmaceutical Da Ren Tang Group is 3.30%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Tianjin Pharmaceutical Da Ren Tang Group was 4.51%. The lowest was 0.16%. And the median was 1.36%.

Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share for the months ended in Dec. 2023 was ¥0.00.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Dividends Per Share Growth Rate was 124.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 55.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 37.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 24.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 55.10% per year. The lowest was -37.00% per year. And the median was 14.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.28

0.37

0.31

0.43

0.91

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	2.59	-	-

Competitive Comparison of Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio falls into.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	1.12	/	1.23
	=	0.91

Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	0.246
	=	0.00

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Tianjin Pharmaceutical Da Ren Tang Group Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Dividend Payout Ratio

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines